Contents

Current Cancer Drug Targets, Volume 5 - Number 4

Antiangiogenic Therapy in Acute Myelogenous Leukemia: Targeting of Vascular Endothelial Growth Factor and Interleukin 8 as Possible Antileukemic Strategies

, 5(4): 229 - 248

Kimberley J. Hatfield, Astrid M. Olsnes, Bjorn Tore Gjertsen and Oystein Bruserud


DOI: 10.2174/1568009054064651




The Chick Embryo Chorioallantoic Membrane as a Model System for the Study of Tumor Angiogenesis, Invasion and Development of Anti-Angiogenic Agents

, 5(4): 249 - 266

A. Cevik Tufan and N. Lale Satiroglu-Tufan


DOI: 10.2174/1568009054064624




Squalamine: A Polyvalent Drug of the Future?

, 5(4): 267 - 272

Jean Michel Brunel, Chanaz Salmi, Celine Loncle, Nicolas Vidal and Yves Letourneux


DOI: 10.2174/1568009054064642




The MYCN Oncogene as a Specific and Selective Drug Target for Peripheral and Central Nervous System Tumors

, 5(4): 273 - 283

Andrea Pession and Roberto Tonelli


DOI: 10.2174/1568009054064606




Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics

, 5(4): 285 - 298

F. Mannello, G. Tonti and S. Papa


DOI: 10.2174/1568009054064615




The Anti-Tumor Effect and Mechanisms of Action of Penta-Acetyl Geniposide

, 5(4): 299 - 305

C. H. Peng, C. N. Huang and C. J. Wang


DOI: 10.2174/1568009054064633




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science